title: Intracranial mass of multiple myeloma with good response to chemotherapy.
authors.affiliation: Department of Neurology, St Elisabeth Hospital, Tilburg, Netherlands. n.synhaeve@elisabeth.nl
authors.forename: Nathalie E
authors.initials: NE
authors.lastname: Synhaeve
authors.forename: Cees
authors.initials: C
authors.lastname: van der Heul
authors.forename: Cees C
authors.initials: CC
authors.lastname: Tijssen
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use*; D001897:Boronic Acids / Q000009:adverse effects / Q000627:therapeutic use; D000069286:Bortezomib; D001932:Brain Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy*; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone; D008558:Melphalan